Correlation Between Scpharmaceuticals and Virax Biolabs
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Virax Biolabs Group, you can compare the effects of market volatilities on Scpharmaceuticals and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Virax Biolabs.
Diversification Opportunities for Scpharmaceuticals and Virax Biolabs
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Scpharmaceuticals and Virax is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Virax Biolabs go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Virax Biolabs
Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the Virax Biolabs. But the stock apears to be less risky and, when comparing its historical volatility, Scpharmaceuticals is 1.42 times less risky than Virax Biolabs. The stock trades about -0.2 of its potential returns per unit of risk. The Virax Biolabs Group is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest 228.00 in Virax Biolabs Group on August 26, 2024 and sell it today you would lose (27.00) from holding Virax Biolabs Group or give up 11.84% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. Virax Biolabs Group
Performance |
| Timeline |
| Scpharmaceuticals |
| Virax Biolabs Group |
Scpharmaceuticals and Virax Biolabs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and Virax Biolabs
The main advantage of trading using opposite Scpharmaceuticals and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| Virax Biolabs vs. Eliem Therapeutics | Virax Biolabs vs. HCW Biologics | Virax Biolabs vs. Scpharmaceuticals | Virax Biolabs vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Stocks Directory Find actively traded stocks across global markets |